Page 17 - Graphite Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Graphite Bio (NASDAQ:GRPH – Get Rating) and Cellectis (NASDAQ:CLLS – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation. Valuation and Earnings This table compares Graphite Bio and Cellectis’ […]

Graphite Bio (NASDAQ:GRPH – Get Rating) is one of 262 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its competitors? We will compare Graphite Bio to related companies based on the strength of its institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability. Valuation and Earnings This […]

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the election of Alethia Young to the company's Board of Directors. Ms. Young has more...

BioPharma

Biotechnology stocks and the related exchange traded funds are under pressure as growth stocks stumble this year.